Tandem Diabetes Care
TNDM
84 hedge funds and large institutions have $136M invested in Tandem Diabetes Care in 2016 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 27 increasing their positions, 24 reducing their positions, and 10 closing their positions.
60% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 10
13% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 24
8% more funds holding
Funds holding: 78 → 84 (+6)
0% less capital invested
Capital invested by funds: $136M → $136M (-$294K)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $130K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$3M |
| 2 |
BC
Broadfin Capital
New York
|
+$2.44M |
| 3 |
IHM
Iguana Healthcare Management
New York
|
+$1.42M |
| 4 |
SI
Shaker Investments
Cleveland,
Ohio
|
+$1.25M |
| 5 |
GIP
Granite Investment Partners
El Segundo,
California
|
+$1.12M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Westfield Capital Management
Boston,
Massachusetts
|
-$5.17M |
| 2 |
ACM
Archon Capital Management
Seattle,
Washington
|
-$2.26M |
| 3 |
MFAM
Motley Fool Asset Management
Alexandria,
Virginia
|
-$1.9M |
| 4 |
American Century Companies
Kansas City,
Missouri
|
-$1.86M |
| 5 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$1.8M |
TNDM Hedge Fund Activity: Q3 2016 in Review
84 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Tandem Diabetes Care (TNDM) for Q3 2016, worth a combined $136M — down 0.22% from $136M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new TNDM positions and 10 closed out — a net gain of 6 holders — while 27 added to existing stakes and 24 trimmed.
The largest buyer was DAFNA Capital Management, adding an estimated $3M. The largest seller was Westfield Capital Management, exiting entirely with an estimated $5.17M sold.
- 84 institutional investors held Tandem Diabetes Care (TNDM) as of Q3 2016, up from 78 in Q2 2016.
- Funds reported $136M of Tandem Diabetes Care stock for Q3 2016, down 0.22% quarter-over-quarter.
- 16 funds opened new Tandem Diabetes Care positions in Q3 2016 and 10 closed out, a net change of +6 holders.
- The largest Tandem Diabetes Care buyer in Q3 2016 was DAFNA Capital Management, an estimated $3M added.
- The largest Tandem Diabetes Care seller in Q3 2016 was Westfield Capital Management, an estimated $5.17M sold.
Based on aggregated 13F filings for Q3 2016.